Drug delivery leaps biotech hurdles

November 27, 2002

San Jose, Calif.--December 4, 2002-- While new biotech drugs are touted as the next medical revolution, it's proving to be extremely difficult to get some of them into the body--and to get them to behave properly once they're in. Packaging and delivering proteins and other large molecules is a major hurdle.

"Long a minor concern for pharmaceutical companies, drug delivery is now one very hot topic," says Technical Insights Analyst Katherine Austin. "The pharmaceutical industry is realizing that not only can improved technology deliver particular drugs more effectively or conveniently, it can also extend the life cycle of these products as they lose their coveted patent protection."

Many new technologies are being developed to target drugs directly to where they are needed in the body. These include the attachment of targeting molecules, such as monoclonal antibodies and receptor ligands, to carriers such as liposomes, polymer particles, and nanospheres. A number of labs are even learning how to use soccer-ball-shaped fullerene molecules or algae skeletons as cages to carry and control the release of drugs.

The delivery of cancer drugs is one application for which targeted delivery may prove especially valuable. Because anti-cancer drugs tend to be highly toxic to healthy cells as well as malignant ones, researchers and patients alike hope that it will become easier to target these drugs directly to the tumor, sparing healthy tissues.

New analysis by Technical Insights, a business unit of Frost & Sullivan (www.Technical-Insights.frost.com), Drug Delivery, reveals that over 300 companies are currently developing various avenues of drug delivery. Emerging technologies ranging from medicated powders pumped into the skin at supersonic speeds, to implanted microchips that deliver precise dosages, to nano-molecular transportation systems are growing prospects for drug delivery.

Technical Insights will hold a conference call at 3:00 p.m. (EST)/ 12:00 p.m. (PST) on December 4, 2002 to provide a summary and analysis of the latest developments in drug delivery. Those interested in participating in the call should send an email to Julia Rowell at jrowell@frost.com with the following information for registration:

Full name, Company Name, Title, Contact Tel Number, Contact Fax Number, Email. Upon receipt of the above information, a confirmation/pass code for the live briefing will be emailed to you.

Frost & Sullivan is a global leader in strategic market consulting and training. Acquired by Frost & Sullivan, Technical Insights is an international technology analysis business that produces a variety of technical news alerts, newsletters, and reports. Ongoing analysis on Drug Delivery is covered in Industrial Bioprocessing Alert, a Technical Insights subscription service, and in Biopolymers and Biocompatible Materials, Frost & Sullivan Technical Insights technology reports. Executive summaries and interviews are available to the press.

Drug Delivery
Report: D243

Julia Rowell
P: 210.247.3870
F: 210.348.1003
E: jrowell@frost.com

Pramila Gurtoo
DID : (603) 6204 5811
Gen : (603) 6204 5800
Fax : (603) 6201 7402
E: pgurtoo@frost.com


Technical Insights

Related Drug Delivery Articles from Brightsurf:

Modelling microswimmers for drug delivery
An international group of theoretical physicists led by Abdallah Daddi-Moussa-Ider from Düsseldorf, Germany, has modelled the motion of microscopic, motile bodies - either powered micro-machines or living cells - in viscous liquid drops, using the Navier-Stokes equations.

Millimetre-precision drug delivery to the brain
Focused ultrasound waves help ETH researchers to deliver drugs to the brain with pinpoint accuracy, in other words only to where their effect is desired.

New smart drug delivery system may help treatment for neurological disorders
A Rutgers-led team has created a smart drug delivery system that reduces inflammation in damaged nervous tissues and may help treat spinal cord injuries and other neurological disorders.

Novel drug delivery particles use neurotransmitters as a 'passport' into the brain
Drug-carrying lipid nanoparticles were created that incorporate neurotranmitters to help them cross the blood-brain barrier in mice.

Advances in nanoparticles as anticancer drug delivery vector: Need of this century
This review article provides a summary of current advances in the use of nanoparticles (NPs) as anticancer drug-delivery vectors.

Microcapsules for targeted drug delivery to cancer cells
A team of scientists from Peter the Great St. Petersburg Polytechnic University together with their colleagues developed a method of targeted drug delivery to cancer cells.

Improving drug delivery for brain tumor treatment
Despite improvements in drug delivery mechanisms, treating brain tumors has remained challenging.

Nanoparticle orientation offers a way to enhance drug delivery
MIT engineers have shown that they can enhance the performance of drug-delivery nanoparticles by controlling an inherent trait of chemical structures, known as chirality -- the 'handedness' of the structure.

News about drug delivery
Nanocontainer for drugs can have their pitfalls: If they are too heavily loaded, they will only dissolve poorly.

Deflating beach balls and drug delivery
Gwennou Coupier and his colleagues at Grenoble Alps University, Grenoble, France have shown that macroscopic-level models of the properties of microscopic hollow spheres agree very well with theoretical predictions.

Read More: Drug Delivery News and Drug Delivery Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.